$13.00
-0.33-2.48%
At close: -
$13.00
0.000.00%
After Hours: Dec 20, 4:04 PM EDT
Comments
Loading...
Corbus Pharmaceuticals (CRBP) Forecast
NewsEarningsCorbus Pharmaceuticals (CRBP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCorbus Pharmaceuticals (NASDAQ:CRBP) Stock Quotes, Forecast and News Summary
Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Corbus Pharmaceuticals (CRBP) stock?
You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.
Who are Corbus Pharmaceuticals (CRBP) competitors?
Other companies in Corbus Pharmaceuticals’s space includes: Zura Bio (NASDAQ:ZURA), Invizyne Technologies (NASDAQ:IZTC), Innate Pharma (NASDAQ:IPHA), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).
What is the forecast, or price target, for Corbus Pharmaceuticals (CRBP) stock?
Corbus Pharmaceuticals has a consensus price target of $62.00.
What is the current price for Corbus Pharmaceuticals (CRBP)?
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $13 last updated December 20, 2024 at 4:04 PM EST.
Does Corbus Pharmaceuticals (CRBP) pay a dividend?
There are no upcoming dividends for Corbus Pharmaceuticals.
When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?
Corbus Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, March 11, 2025.
Is Corbus Pharmaceuticals (CRBP) going to split?
There is no upcoming split for Corbus Pharmaceuticals.
What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.